New InnoVet-AMR projects
Innovative Veterinary Solutions for Antimicrobial Resistance (InnoVet-AMR) is a four-year, CA$27.9 million partnership between IDRC and the UK government’s Global AMR Innovation Fund (GAMRIF), part of the Department of Health and Social Care (DHSC).
InnoVet-AMR addresses the emerging global threat of antimicrobial resistance by minimizing the misuse of antibiotics in animal production in the Global South.
IDRC and DHSC wish to achieve two key objectives through InnoVet-AMR:
- support research that will identify innovative veterinary solutions, including vaccines and alternative solutions, to reduce the use of antimicrobials in livestock and aquaculture operations in low and middle-income countries; and
- build effective partnerships to better coordinate the discovery, development, and sustainable delivery of innovative veterinary solutions to reduce the use of antimicrobials in livestock and aquaculture operations in low and middle-income countries. InnoVet-AMR projects focus on reducing the use of antibiotics in the poultry, swine, and aquaculture sectors in low and middle-income countries.